HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)

SHA:600829 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 24, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,164	4,349	4,535	3,700	3,897	4,303
Market Cap Growth	18.00%	-4.09%	22.57%	-5.06%	-9.43%	8.80%
Enterprise Value	4,251	4,499	4,654	3,912	4,575	4,515
Last Close Price	7.18	7.50	7.62	6.22	6.55	7.09
PE Ratio	23.03	20.39	15.52	13.99	14.05	29.62
PS Ratio	0.41	0.43	0.44	0.38	0.42	0.54
PB Ratio	1.42	1.51	1.65	1.51	1.77	2.16
P/TBV Ratio	1.44	1.52	1.66	1.52	1.80	2.19
P/FCF Ratio	29.44	40.50	14.65	12.30	-	-
P/OCF Ratio	27.94	37.68	13.62	12.04	-	-
EV/Sales Ratio	0.42	0.45	0.45	0.41	0.49	0.56
EV/EBITDA Ratio	13.07	14.10	10.78	9.69	10.48	16.26
EV/EBIT Ratio	16.03	15.00	11.31	10.21	11.08	17.86
EV/FCF Ratio	30.06	41.89	15.04	13.00	-	-
Debt / Equity Ratio	0.28	0.31	0.37	0.52	0.60	0.31
Debt / EBITDA Ratio	2.56	2.50	2.16	2.84	2.80	2.20
Debt / FCF Ratio	5.89	8.38	3.29	4.22	-	-
Asset Turnover	1.39	1.38	1.44	1.40	1.46	1.39
Inventory Turnover	8.92	8.29	8.59	8.02	7.48	6.26
Quick Ratio	1.35	1.33	1.27	1.22	1.15	1.11
Current Ratio	1.63	1.62	1.53	1.48	1.42	1.43
Return on Equity (ROE)	6.28%	7.57%	11.22%	11.36%	13.19%	7.55%
Return on Assets (ROA)	2.28%	2.57%	3.55%	3.47%	4.05%	2.74%
Return on Capital (ROIC)	4.28%	4.96%	6.86%	6.60%	8.42%	6.35%
Return on Capital Employed (ROCE)	8.60%	9.90%	14.20%	14.60%	17.30%	11.90%
Earnings Yield	4.34%	4.90%	6.44%	7.15%	7.12%	3.38%
FCF Yield	3.40%	2.47%	6.83%	8.13%	-6.29%	-0.54%
Dividend Yield	2.00%	-	1.89%	-	-	1.69%
Payout Ratio	91.32%	75.22%	8.43%	11.53%	12.86%	2.93%
Buyback Yield / Dilution	0.02%	0.01%	-0.01%	0.00%	0.20%	-0.20%
Total Shareholder Return	2.02%	0.01%	1.88%	0.00%	0.20%	1.49%

Updated Oct 21, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.